OPXS

• Overall Business Performance & External Impacts

  • The first half of FY2026 was negatively impacted by the U.S. federal government shutdown and delays in approval of the FY2026 appropriations bill, which pushed multiple contract awards into the second half of the fiscal year
  • Gross margin improvement was driven by the completion of legacy loss-making Periscope contracts, improved pricing on newer programs, and ongoing operational efficiencies
  • New first-half orders grew 3.8% year-over-year to $16.3 million, ending backlog stands at approximately $36.6 million, providing strong visibility for the remainder of FY2026, with steady order bookings across core defense programs

• Investment Activities

  • Increased operating expenses year-over-year are primarily driven by leadership transition costs, organizational restructuring, higher stock-based compensation, increased R&D investment, ongoing compliance work, and internal systems upgrades, with minor additional pressure from inflation
  • The company invested $0.8 million in capital equipment during the first half, with $1.1 million in additional committed capital investments; full-year capital expenditures are projected to fall between $2 million and $2.5 million
  • All capital investments support capacity expansion, new product line development, expanded R&D activity, and enhanced prototyping capabilities

• Balance Sheet and Cash Flow

  • The company ended Q2 with $4.2 million in cash and cash equivalents, with no outstanding debt on its revolving credit facility
  • Operating cash flow saw a $1.3 million outflow in the first half, compared to a $4.0 million inflow in the prior year, driven by higher operating expenses and increased inventory purchases to prepare for expected second-half revenue growth
  • Working capital remains strong at $22.6 million, up from $21.1 million at the end of the prior fiscal year

• Strategic Priorities

  • Management is focused on near-term execution, operational efficiency, and delivering value to customers, defense warfighters, and shareholders
  • Recent investments in R&D, manufacturing capabilities, and organizational structure are intended to position the company for long-term growth and expanded market opportunities

• Full-year FY2026 revenue guidance is maintained at $43 million to $45 million, with management expecting significantly stronger revenue performance in the second half as delayed government contract awards move forward and awarded programs ramp up into production
• Full-year adjusted EBITDA guidance is maintained at $7.5 million to $8.5 million
• Full-year capital expenditure guidance is set at $2 million to $2.5 million
• Operating expenses are expected to remain elevated for the rest of the fiscal year as the company continues R&D investment, works toward cybersecurity maturity model certification, and upgrades internal reporting systems

The provided transcript does not break out financial performance for distinct product segments, only presenting consolidated company-wide results. Consolidated Q2 FY2026 revenue was $9.6 million (the transcript has a noted typo of 96 million) compared to $10.7 million in the prior year Q2. Consolidated year-to-date (first six months) revenue was $18.8 million, essentially flat compared to $18.9 million in the prior year period. Consolidated Q2 gross profit was $3.4 million, with a gross margin of 35.2% (up from 31.3% YoY). Year-to-date gross profit was $5.5 million, with a gross margin of 29.2% (up from 29.0% YoY). Consolidated Q2 operating expenses were $1.7 million (up $0.6 million YoY), year-to-date operating expenses were $3.7 million (up $1.4 million YoY). Consolidated Q2 net income was $1.3 million ($0.19 per diluted share) compared to $1.8 million YoY, and year-to-date net income was $1.6 million ($0.23 per diluted share) compared to $2.6 million YoY.

• Forward-looking statements made during the call are subject to known and unknown risks and uncertainties that could cause actual results to differ materially from projections; key risk factors are detailed in the company's SEC filings, including the risk factors section of its most recent 10-K
• Additional potential risks cited include ongoing government funding delays, inflationary cost pressures, and the need to complete cybersecurity certification requirements and internal systems upgrades that will keep operating expenses elevated

No questions were submitted by call participants during the open question and answer period, so no exchanges occurred.